These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 934519

  • 41. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
    Klieber M, Resch F.
    Wien Klin Wochenschr; 1986 Feb 07; 98(3):70-3. PubMed ID: 2938341
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H, Dudczak R, Lechner K.
    Dtsch Med Wochenschr; 1973 Nov 30; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract] [Full Text] [Related]

  • 44. [Study of the sphygmic periods and segmental pressure in the limbs of normal subjects and arteriopathic patients].
    Picchione N, Caini B.
    Cardiol Prat; 1976 Nov 30; 27(2):83-95. PubMed ID: 1026355
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 30; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 Aug 30; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Therapeutic physical exercise in the preoperative preparation of patients with obliterative vascular diseases of the legs].
    Kulikov IuA, Dzhuraeva LA, Avazmatova KhR, Ismailova DA.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989 Aug 30; (1):53-5. PubMed ID: 2711639
    [No Abstract] [Full Text] [Related]

  • 54. [On the behavior of lipidemia, blood viscosity and arterial flow of the limbs after oral lipid loading. Observations in subjects with peripheral obliterating arteriopathies].
    Bartoli V, Dorigo B, Ponzeveroni A, Barletta O.
    Mal Cardiovasc; 1969 Aug 30; 10(4):651-62. PubMed ID: 5405783
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
    Artale F, Sergio G, Cramarossa L, Giunti P, Francisci A, Perego MA.
    Ric Clin Lab; 1983 Aug 30; 13 Suppl 3():411-5. PubMed ID: 6673022
    [Abstract] [Full Text] [Related]

  • 59. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V, Gabrielli F.
    Minerva Med; 1983 Mar 31; 74(13):685-9. PubMed ID: 6220230
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.